Entity family
Organisations named as supporting, sponsoring, or funding research. Examples include Wellcome, NIHR, research councils.
This funder is selected. Its supporting articles are shown below.
…ion and Objectives The phase 3 COUGH-1/-2 trials ( NCT03449134, NCT03449147) demonstrated that gefapixant 45 mg twice daily (BID) is effect…
…ough in phase 3 trials of gefapixant (COUGH-1/-2 [ NCT03449134, NCT03449147]) included the Leicester Cough Questionnaire (LCQ) and cough se…
…h PROs vs PGIC in two phase 3 trials (COUGH-1/-2 [ NCT03449134, NCT03449147]).Methods COUGH-1/-2 methods have previously been reported (McG…